Clinical Trials Logo

Pituitary Neoplasms clinical trials

View clinical trials related to Pituitary Neoplasms.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06234553 Active, not recruiting - Pituitary Adenoma Clinical Trials

Application of Radiomics in the Diagnosis and Treatment Prediction of Pituitary Adenoma

RIPA
Start date: January 1, 2022
Phase:
Study type: Observational

The images of patients with Pituitary adenoma were collected and analyzed based on the methods of radiomics.

NCT ID: NCT04218721 Active, not recruiting - Clinical trials for Renal Transplant Recipients

Implementing eHealth Interventions Into Regular Clinical Practice

InvolveMe
Start date: April 24, 2020
Phase: N/A
Study type: Interventional

The purpose with this study is to test a digital patient-provider communication tool for symptom and needs management among patients with chronic health conditions.

NCT ID: NCT04042753 Active, not recruiting - Pituitary Tumor Clinical Trials

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

Start date: July 31, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if nivolumab and ipilimumab are effective treatment for people with pituitary tumors have gotten worse after surgery and radiation.

NCT ID: NCT03665064 Active, not recruiting - Pituitary Diseases Clinical Trials

Long Term Outcome Study in Patients With Pituitary Disorders

Start date: January 1, 2000
Phase:
Study type: Observational

To determine the outcomes of patients with different pituitary disorders whether they are managed medically, surgically or expectantly.

NCT ID: NCT03636568 Active, not recruiting - Surgery Clinical Trials

Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)

DHAPS
Start date: June 2, 2016
Phase: N/A
Study type: Interventional

Hyponatremia is defined as sodium below the normal range of 135-145. Symptomatically, it can cause patients to experience a wide range of symptoms including lethargy, headache, nausea, vomiting and in severe cases coma and even death. The goal of this study is to prospectively compare two approaches to the postoperative fluid management of patients undergoing transsphenoidal resection of a pituitary tumor or cyst to decrease the occurrence of postoperative delayed hyponatremia. One group will be placed on moderate fluid restriction and the other group will be placed on ad lib fluid intake.

NCT ID: NCT03465618 Active, not recruiting - Brain Cancer Clinical Trials

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Start date: March 7, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test if PET scans using 89Zr-DFO-cRGDY-PEG-Cy5-C' dot particles, can be used to take pictures of brain tumors. The investigators want to understand how the particles are distributed and removed from the body, which may help others be treated in the future. This will be the first time that 89Zr-DFO-cRGDY-PEG-Cy5-C' dot particles are being used in people. The amount of particles given in this study is very small compared to the amount that was used in mice animal studies.

NCT ID: NCT03282058 Active, not recruiting - Pituitary Tumour Clinical Trials

Silastic Stent Study

Start date: April 4, 2016
Phase: N/A
Study type: Interventional

Endoscopic skull base surgery is a relatively new procedure that is now a standard of care for surgeries at the base of the skull; however there are no studies that examine the healing process of the nasal lining with the use of silastic (silicone) stents (or splints) that might be placed at the time of surgery. While there is some evidence to suggest that the use of stents improves wound healing, the decision to use a stent or not is currently up to the preference of the surgeon. To investigate the impact of stents on post-surgical healing, the investigators at Vancouver General Hospital will compare patients undergoing trans-sphenoidal pituitary surgeries with septal flap reconstruction with the use of silastic stents to line the septal donor site, and compare their recovery to those who did not receive stents. The investigators hypothesize that the use of silastic stents in endonasal surgery increases the rate of mucosal healing, and better quality mucosal regeneration, and with no effect on the patients experience after surgery. In this randomized control trial the investigators aim to recruit 26 (13 in each arm) study participants. The primary outcome is to determine the effect of silastic stunting on healing of the naso-septal flap donor site. This objective will be achieved by assessment of endoscopic photographs of healing tissue and histologic assessment of healing tissues. The secondary outcome involves questionnaires that measure the patient's subjective nasal symptoms prior to and following endoscopic skull based surgery. Total time commitment for the study participant is about 4 months across 4 study visits (all of which are part of standard of care): the assessment visit, surgery, 4 weeks post-operative follow up visit and 12 week post-operative follow up visit.

NCT ID: NCT01794793 Active, not recruiting - Prostate Cancer Clinical Trials

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Start date: June 10, 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to allow continued use of pasireotide in patients who are on pasireotide treatment in a Novartis-sponsored study and are benefiting from the treatment as judged by the investigator.